USFDA completes GMP inspection at Glenmark Pharma’s facility at Aurangabad

21 Sep 2024 Evaluate

United States Food & Drug Administration (USFDA) completed a Good Manufacturing Practice (GMP) inspection at the Glenmark Pharmaceuticals’ formulation manufacturing facility based out of Chhatrapati Sambhaji Nagar (Aurangabad), India. The inspection was conducted from September 09 to September 20, 2024. The inspection closed with no observation.

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries. 


Glenmark Pharma Share Price

1636.05 -2.90 (-0.18%)
03-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.10
Dr. Reddys Lab 1352.75
Cipla 1510.25
Lupin 2367.85
Zydus Lifesciences 975.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.